Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2022, 166(4):412-417 | DOI: 10.5507/bp.2022.030
Myringosclerosis as a predictor of the requirement for a permanent pacemaker in patients with drug-related atrioventricular block
- a Department of Cardiology, Mengucek Gazi Education and Research Hospital, Medical Faculty, Erzincan Binali Yildirim University, Erzincan, Turkey
- b Department of Cardiology, Omer Halisdemir Education and Research Hospital, Nigde, Turkey
- c Department of ENT, Mengucek Gazi Education and Research Hospital, Medical Faculty, Erzincan Binali Yildirim University, Erzincan, Turkey
Aims: Drug-related atrioventricular block (DR-AVB) may develop in patients with underlying latent degenerative conduction disorders, especially with antiarrhythmics and antihypertensives. Although, according to the current guidelines, reversal is achieved with cessation of the inducing agent, this is not the case for nearly half of the patients. The pathophysiological processes of DR-AVB and myringosclerosis include systemic inflammation and degeneration. This study investigated the role of myringosclerosis in predicting irreversible high-grade DR-AVB despite drug cessation.
Methods: This observational, non-randomized, prospective study involved 152 patients with high-grade DR-AVB, 72 of whom had reversible DR-AVB and 80 had irreversible DR-AVB and required permanent pacemakers. The patients' demographic, clinical, echocardiographic, and laboratory characteristics were recorded. Otoscopic tympanic membrane examinations for myringosclerosis were performed.
Results: There were no major differences in demographic, echocardiographic or laboratory characteristics between the two groups or previous medications. The median monitoring time with a temporary pacemaker was significantly longer in the irreversible than in the reversible group (5 [4-7] days vs. 2 [1-5] days; P<0.001). The incidence of myringosclerosis was significantly higher in the irreversible than in the reversible group (61.3% vs. 22.2%; P=0.001). Multivariate logistic regression analysis showed that myringosclerosis was an independent predictor of irreversible DR-AVB (odds ratio: 1.703, 95% confidence interval: 1.194-3.058; P=0.01).
Conclusion: Myringosclerosis is a readily available, inexpensive, and non-invasive assessment and is a marker of inflammation and degeneration that can predict irreversible DR-AVB.
Keywords: atrioventricular block, myringosclerosis, pacemaker, tympanosclerosis
Received: February 15, 2022; Revised: June 6, 2022; Accepted: June 15, 2022; Prepublished online: June 21, 2022; Published: December 7, 2022 Show citation
ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- Lee JH, Ryu HM, Bae MH, Kwon YS, Lee JH, Park Y, Heo J-H, Lee YS, Yang DH, Park HS. Prognosis and natural history of drug-related bradycardia. Korean circ j 2009;39(9):367-71.
Go to original source...
Go to PubMed...
- Zeltser D, Justo D, Halkin A, Rosso R, Ish-Shalom M, Hochenberg M, Viskin S. Drug-induced atrioventricular block: prognosis after discontinuation of the culprit drug. J Am Coll Cardiol 2004;44(1):105-8.
Go to original source...
Go to PubMed...
- Kawabata M, Yokoyama Y, Sasaki T, Tao S, Ihara K, Shirai Y, Sasano T, Goya M, Furukawa T, Isobe M. Severe iatrogenic bradycardia related to the combined use of beta-blocking agents and sodium channel blockers. Clin Pharmacol 2015;7:29.
Go to original source...
Go to PubMed...
- Kennebäck G, Tabrizi F, Lindell P, Nordlander R. High-degree atrioventricular block during anti-arrhythmic drug treatment: use of a pacemaker with a bradycardia-detection algorithm to study the time course after drug withdrawal. Europace 2007;9(3):186-91.
Go to original source...
Go to PubMed...
- Glikson M, Nielsen JC, Kronborg MB, Michowitz Y, Auricchio A, Barbash IM, Barrabes JA, Boriani G, Braunschweig F, Brignole M, Burri H, Coats A, Deharo J-C, Delgado V, Diller G-P, Israel CW, Keren A, Knops RE, Kotecha D, Leclercq C, Merkely B, Starck C, Thylen I, Tolosana JM. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology (ESC) With the special contribution of the European Heart Rhythm Association (EHRA). Eur Heart J 2021;42(35):3427-520.
Go to original source...
Go to PubMed...
- Knudsen MB, Thøgersen AM, Hjortshøj SP, Riahi S. The impact of drug discontinuation in patients treated with temporary pacemaker due to atrioventricular block. J Cardiovas Electrophysiol 2013;24(11):1255-8.
Go to original source...
Go to PubMed...
- Jordán-Martínez L, Rivera-López R, Bermúdez-Jiménez F, Jiménez-Jaimez J, Alzueta J, Barrera-Cordero A, Rivera-Fernández R, Jiménez-Navarro M, Álvarez M, Tercedor L. Atrioventricular block in patients undergoing treatment with bradycardic drugs. Predictors of pacemaker requirement. Rev Esp Cardiol (English ed) 2020;73(7):554-60.
Go to original source...
- Şenöz O, Erseçgin A. Systemic immune-inflammation index as a tool for predicting the need for a permanent pacemaker in patients with drug-induced atrioventricular block. Pacing Clin Electrophysiol 2021;44(12):1972-8.
Go to original source...
Go to PubMed...
- Forséni M, Eriksson A, Bagger-Sjöbäck D, Nilsson J, Hultcrantz M. Development of tympanosclerosis: can predicting factors be identified? Am J Otol 1997;18(3):298-303.
- Pirodda A, Bruzzi C, Ferri GG, Modugno GC, Gaddi A. Otoscopic findings in hypercholesterolemic subjects. B-ent 2010;6(2):123-6.
Go to PubMed...
- Buyanover D, Tietz A, Luntz M, Sadé J. The biochemical composition of tympanosclerotic deposits. Arch Otorhinolaryngol 1987;243(6):366-9.
Go to original source...
Go to PubMed...
- Ferlito A. Histopathogenesis of tympanosclerosis. J Laryngol Otol 1979;93(1):25-37.
Go to original source...
Go to PubMed...
- House WF, Sheehy JL. Tympanosclerosis. Arch Otorhinolaryngol 1960;72(3):308-13.
Go to original source...
- Sheehy JL, House WF. Tympanosclerosis. Arch Otorhinolaryngol 1962;76(2):151-7.
Go to original source...
Go to PubMed...
- Shanahan CM, Cary N, Metcalfe JC, Weissberg PL. High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin Invest 1994;93(6):2393-402.
Go to original source...
Go to PubMed...
- Hirota S, Imakita M, Kohri K, Ito A, Morii E, Adachi S, Kim HM, Kitamura Y, Yutani C, Nomura S. Expression of osteopontin messenger RNA by macrophages in atherosclerotic plaques. A possible association with calcification. Am J Pathol 1993;143(4):1003.
- O'Brien KD, Kuusisto J, Reichenbach DD, Ferguson M, Giachelli C, Alpers CE, Otto CM. Osteopontin is expressed in human aortic valvular lesions. Circ J 1995;92(8):2163-8.
Go to original source...
Go to PubMed...
- Koç A, Üneri C. Ultrastructural comparison between tympanosclerosis and atherosclerosis. Türk Otolarengol Arş 2005;43(3):137-44.
- Tos M, Stangerup S-E. Hearing loss in tympanosclerosis caused by grommets. Arc Otolaryngol Head Neck Surg 1989;115(8):931-5.
Go to original source...
Go to PubMed...
- Iriz A, Eryilmaz A, Gocer C, Acar A, Boynuegri S, Dursun E. Could Helicobacter pylori play a role in the aetiopathogenesis of tympanosclerosis? J Laryngol Otol 2011;125(11):1121-4.
Go to original source...
Go to PubMed...
- Koç A, Uneri C. Genetic predisposition for tympanosclerotic degeneration. Eur Arch Otorhinolaryngol 2002;259(4):180-3.
Go to original source...
- Pirodda A, Ferri GG, Bruzzi C, Marini M, Faggioli G. Possible relationship between tympanosclerosis and atherosclerosis. Acta Otolaryngol 2004;124(5):574-6.
Go to original source...
Go to PubMed...
- Ferri M, Faggioli GL, Ferri GG, Pirodda A. Is carotid stenosis correlated with tympanosclerosis. Int Angiol 2004;23(2):144-6.
Go to PubMed...
- Doluoglu S, Gocer C, Toprak U, Iriz A, Uyar M, Eryilmaz A. Increased carotid artery intima-media thickness in patients with tympanosclerosis: Common risk factors with atherosclerosis? Kaohsiung J Med Sci 2015;31(4):199-202.
Go to original source...
Go to PubMed...
- Barra SN, Providência R, Paiva L, Nascimento J, Marques AL. A review on advanced atrioventricular block in young or middle-aged adults. Pacing Clin Electrophysiol 2012;35(11):1395-405.
Go to original source...
Go to PubMed...
- Duarte T, Gonçalves S, Sá C, Marinheiro R, Fonseca M, Farinha J, Rodrigues R, Seixo F, Parreira L, CariaR. Permanent cardiac pacing for patients with iatrogenic or potentially reversible bradyarrhythmia. Rev Portuguesa Cardiol 2019;38(2):105-11.
Go to original source...
Go to PubMed...
- Metkus TS, Schulman SP, Marine JE, Eid SM. Complications and Outcomes of Temporary Transvenous Pacing: An Analysis of > 360,000 Patients From the National Inpatient Sample. Chest 2019;155(4):749-57.
Go to PubMed...
- Ciçek D, Vayisoğlu Y, Görür K, Camsari A, Ozcan IT, Akçay B, Kara AA. Is there any relation between coronary atherosclerosis and tympanosclerosis? Anatol J Cardiol 2010;10(2):121-5.
Go to original source...
Go to PubMed...
- Selcuk A, Ozlu F, Akdogan O, Ozbek C, Dere H. Is there a relationship between myringosclerosis and atherosclerosis? B-ent 2007;3(3):127-30.
Go to PubMed...
- Irfan M, Khan I, Ullah Bacha K. Delays in Temporary and Permanent Pacemakers: Causes and In-Hospital Outcomes. Cureus. 2020;12(2):e6953.
Go to original source...
Go to PubMed...
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.